HB 2302, 83rd R.S. history

Help | Status


HB 2302, 83rd R.S.
Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.

Last action: Committee report sent to Calendars

Author: Tan Parker

Session Law Chapter:
Acts 2013, 83rd R.S.,ch. 1290, General and Special Laws of Texas

Signed legislation

Bill Analyses:
Engrossed (Senate Research Center)
Committee Report (Senate Research Center)
Committee Report (House Research Organization)

Subjects:
HEALTH & HUMAN SERVICES COMMISSION
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
INFORMED CONSENT
MEDICAL BOARD, TEXAS
MEDICAL FREEDOM ACT
MEDICINE & PRESCRIPTION DRUGS

House Committee: Public Health (Senfronia Thompson, Steve Allison, Garnet Coleman, James B. Frank, R. D. "Bobby" Guerra, Eddie Lucio III, Evelina "Lina" Ortega, Four Price, J. D. Sheffield, John Wray, Bill Zedler)

Index to Sections Affected

Texas Legislature Online


The Legislative Archive System is a work in progress. Complete information is not available for all bills and all sessions. Visit the Legislative Archive System status page for details. Please contact the Legislative Reference Library at 512-463-1252 if you have any questions. Information on this website is provided as a public service by the Legislative Reference Library. The Legislative Reference Library makes no representation as to its completeness or accuracy and makes no warranty in regard to its use. Users assume all risk of reliance on the information included on this site.